These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28319697)

  • 1. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women.
    Wang SY; Duan KM; Tan XF; Yin JY; Mao XY; Zheng W; Wang CY; Yang M; Peng C; Zhou HH; Liu ZQ
    J Affect Disord; 2017 Jun; 215():94-101. PubMed ID: 28319697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IDO genetic polymorphisms and postpartum depressive symptoms: an association study in Chinese parturients who underwent cesarean section.
    Duan KM; Wang SY; Yin JY; Li X; Ma JH; Huang ZD; Zhou YY; Yu HY; Yang M; Zhou HH; Liu ZQ
    Arch Womens Ment Health; 2019 Jun; 22(3):339-348. PubMed ID: 30121843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of kynurenine pathway and kynurenic aminotransferase alleles in postpartum depression following cesarean section in Chinese women.
    Quan C; Wang S; Duan K; Ma J; Yu H; Yang M; Hu N; Long G; Zeng G; Huang Z
    Brain Behav; 2020 Apr; 10(4):e01566. PubMed ID: 32101387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between kynurenine metabolites and postpartum depression].
    Wang S; Quan C; Tan Y; Wen S; Zhang J; Duan K
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):725-731. PubMed ID: 30124207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between GRIN2B and GRIN3A gene polymorphisms and postpartum depressive symptoms in Chinese parturients undergoing cesarean section: A prospective cohort study.
    Ping A; Yang M; Xu S; Li Q; Feng Y; Gao K; Wang S; Duan K
    J Psychosom Res; 2023 May; 168():111210. PubMed ID: 36898314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Study Between Kynurenine 3-Monooxygenase (KMO) Gene and Parkinson's Disease Patients.
    Babu HWS; Elangovan A; Iyer M; Kirola L; Muthusamy S; Jeeth P; Muthukumar S; Vanlalpeka H; Gopalakrishnan AV; Kadhirvel S; Kumar NS; Vellingiri B
    Mol Neurobiol; 2024 Jul; 61(7):3867-3881. PubMed ID: 38040995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
    Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
    Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine.
    Kubota H; Kunisawa K; Niijima M; Hirakawa M; Mori Y; Hasegawa M; Fujigaki S; Fujigaki H; Yamamoto Y; Saito K; Nabeshima T; Mouri A
    Biochem Biophys Res Commun; 2022 Nov; 629():142-151. PubMed ID: 36116377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls.
    Holtze M; Saetre P; Engberg G; Schwieler L; Werge T; Andreassen OA; Hall H; Terenius L; Agartz I; Jönsson EG; Schalling M; Erhardt S
    J Psychiatry Neurosci; 2012 Jan; 37(1):53-7. PubMed ID: 21693093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viability of diffuse large B-cell lymphoma cells is regulated by kynurenine 3-monooxygenase activity.
    Morita N; Hoshi M; Hara T; Ninomiya S; Enoki T; Yoneda M; Tsurumi H; Saito K
    Oncol Lett; 2021 Nov; 22(5):790. PubMed ID: 34584567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
    Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
    PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients.
    Oxenkrug G; van der Hart M; Roeser J; Summergrad P
    Integr Clin Med; 2017; 1(1):. PubMed ID: 28748226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of the association between the kynurenine-3-monooxygenase gene and depression].
    Lezheiko TV; Golimbet VE; Andryushchenko AV; Melik-Pashayan AE; Mironova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):92-95. PubMed ID: 28139632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of kynurenine-3-monooxygenase gene with schizophrenia].
    Golimbet VE; Lezheiko TV; Alfimova MV; Abramova LI; Kondrat'ev NV
    Genetika; 2014 Jun; 50(6):724-8. PubMed ID: 25715464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.
    Giorgini F; Huang SY; Sathyasaikumar KV; Notarangelo FM; Thomas MA; Tararina M; Wu HQ; Schwarcz R; Muchowski PJ
    J Biol Chem; 2013 Dec; 288(51):36554-66. PubMed ID: 24189070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
    Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
    Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
    Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
    J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
    Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H
    J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine 3-monooxygenase deficiency induces depression-like behavior via enhanced antagonism of α7 nicotinic acetylcholine receptors by kynurenic acid.
    Mori Y; Mouri A; Kunisawa K; Hirakawa M; Kubota H; Kosuge A; Niijima M; Hasegawa M; Kurahashi H; Murakami R; Hoshi M; Nakano T; Fujigaki S; Fujigaki H; Yamamoto Y; Nabeshima T; Saito K
    Behav Brain Res; 2021 May; 405():113191. PubMed ID: 33607168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenine 3-monooxygenase limits de novo NAD
    Zhai Y; Chavez JA; D'Aquino KE; Meng R; Nawrocki AR; Pocai A; Wang L; Ma LJ
    Am J Physiol Cell Physiol; 2024 May; 326(5):C1423-C1436. PubMed ID: 38497113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.